女性避孕药市场：依避孕药、避孕器具、配销通路- 全球预测 2023-2030

预计到 2023 年，全球女性避孕药具市场将大幅成长，达到 93.2221 亿美元，年复合成长率为 6.39%，预计到 2030 年将达到惊人的 144.0402 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球女性避孕药市场至关重要。透过检视业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使用户能够根据自己的具体需求做出资讯的决策。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 全球女性避孕药市场规模及预测为何？

2.在预测期内，COVID-19对全球女性避孕药具市场的阻碍因素与影响有哪些？

3. 在预测期内，全球女性避孕药市场需要投资哪些产品/细分市场/用途/领域？

4.全球女性避孕药市场的竞争策略是什么？

5. 全球女性避孕药市场的技术趋势和法律规范是什么？

6.全球女性避孕药市场主要厂商的市占率是多少？

7. 哪些型态和策略性措施被认为适合进入全球女性避孕药市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 意外怀孕和性行为感染感染的发生率增加
    • 加强政府配合措施，提高人们对意外怀孕和人口成长的认识
    • 避孕药具种类繁多且易于获取
  • 抑制因素
    • 避孕药的副作用
  • 机会
    • 避孕方法的可用性，例如植入式避孕药和新型避孕药
    • 政府和非政府组织支持新兴经济体避孕推广计划
  • 任务
    • 对各种避孕药具的社会耻辱与误解
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章女性避孕药市场：依避孕药分类

• 介绍
• 避孕针剂
• 口服避孕药
  • 荷尔蒙药物
  • 非荷尔蒙药物
• 杀精剂
• 局部避孕药

第7章女性避孕药市场：依避孕器

• 介绍
• 避孕贴片
• 避孕海绵
• 隔膜和盖子
• 女用保险套
• 避孕器
• 皮下植入避孕药
• 避孕环

第8章女性避孕药市场：依配销通路

• 介绍
• 诊所
• 医院药房
• 独立药房
• 网路平台

第9章美洲女性避孕药市场

• 介绍
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第10章亚太女性避孕药市场

• 介绍
• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第11章欧洲、中东和非洲女性避孕药市场

• 介绍
• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第12章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

• 讨论指南
• 关于许可证和定价

The Global Female Contraceptive Market is forecasted to grow significantly, with a projected USD 9,322.21 million in 2023 at a CAGR of 6.39% and expected to reach a staggering USD 14,404.02 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Female Contraceptive Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Female Contraceptive Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Contraceptive Drug, market is studied across Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives. The Contraceptive Pills is further studied across Hormonal Pills and Non-Hormonal Pills. The Topical Contraceptives is projected to witness significant market share during forecast period.

Based on Contraceptive Devices, market is studied across Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps, Female Condoms, Intra Uterine Contraceptive Devices, Sub-Dermal Contraceptive Implants, and Vaginal Rings. The Sub-Dermal Contraceptive Implants is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Clinic, Hospital Pharmacy, Independent Pharmacy, and Online Platform. The Clinic is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Female Contraceptive Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Female Contraceptive Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Female Contraceptive Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Female Contraceptive Market?

4. What is the competitive strategic window for opportunities in the Global Female Contraceptive Market?

5. What are the technology trends and regulatory frameworks in the Global Female Contraceptive Market?

6. What is the market share of the leading vendors in the Global Female Contraceptive Market?

7. What modes and strategic moves are considered suitable for entering the Global Female Contraceptive Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Female Contraceptive Market, by Contraceptive Drug, 2022 vs 2030
• 4.3. Female Contraceptive Market, by Contraceptive Devices, 2022 vs 2030
• 4.4. Female Contraceptive Market, by Distribution Channel, 2022 vs 2030
• 4.5. Female Contraceptive Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of unwanted pregnancies and sexually transmitted diseases
    • 5.1.1.2. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
    • 5.1.1.3. Multiple types and ease of availability of contraceptives
  • 5.1.2. Restraints
    • 5.1.2.1. Side effects of contraceptive drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Availability of contraceptives method such as Sino-Implants and novel contraceptive
    • 5.1.3.2. Government and non-government organizations supporting programs to encourage contraception in emerging economies
  • 5.1.4. Challenges
    • 5.1.4.1. Social stigma and misconceptions about different contraceptives
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Female Contraceptive Market, by Contraceptive Drug

• 6.1. Introduction
• 6.2. Contraceptive Injections
• 6.3. Contraceptive Pills
  • 6.3.1. Hormonal Pills
  • 6.3.2. Non-Hormonal Pills
• 6.4. Spermicides
• 6.5. Topical Contraceptives

7. Female Contraceptive Market, by Contraceptive Devices

• 7.1. Introduction
• 7.2. Contraceptive Patches
• 7.3. Contraceptive Sponges
• 7.4. Diaphragms & Caps
• 7.5. Female Condoms
• 7.6. Intra Uterine Contraceptive Devices
• 7.7. Sub-Dermal Contraceptive Implants
• 7.8. Vaginal Rings

8. Female Contraceptive Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Clinic
• 8.3. Hospital Pharmacy
• 8.4. Independent Pharmacy
• 8.5. Online Platform

9. Americas Female Contraceptive Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Female Contraceptive Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Female Contraceptive Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. FEMALE CONTRACEPTIVE MARKET RESEARCH PROCESS
• FIGURE 2. FEMALE CONTRACEPTIVE MARKET SIZE, 2022 VS 2030
• FIGURE 3. FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2022 VS 2030 (%)
• FIGURE 5. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2022 VS 2030 (%)
• FIGURE 6. FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• FIGURE 7. FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. FEMALE CONTRACEPTIVE MARKET DYNAMICS
• FIGURE 9. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. FEMALE CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 5. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 7. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 13. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS & CAPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES , BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 39. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 40. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 41. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 61. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 62. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 63. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 65. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 66. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 134. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 135. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 136. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 150. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 151. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 152. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 154. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 155. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 156. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 193. FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 194. FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 195. FEMALE CONTRACEPTIVE MARKET LICENSE & PRICING